Vanguard, BlackRock buy into Boston Scientific’s turnaround February 12, 2014 By Brad Perriello Leave a Comment Count mutual fund giant Vanguard Group and hedge fund BlackRock Inc. among the believers in the comeback story at Boston Scientific (NYSE:BSX).